Accéder au contenu
Merck

Earl Sutherland (1915-1974) [corrected] and the discovery of cyclic AMP.

Perspectives in biology and medicine (2012-05-31)
Stanley A Blumenthal
RÉSUMÉ

In 1945, Earl Sutherland (1915-1974) [corrected] and associates began studies of the mechanism of hormone-induced glycogen breakdown in the liver. In 1956, their efforts culminated in the identification of cyclic AMP, an ancient molecule generated in many cell types in response to hormonal and other extracellular signals. Cyclic AMP, the original "second messenger," transmits such signals through pathways that regulate a diversity of cellular functions and capabilities: metabolic processes such as lipolysis and glycogenolysis; hormone secretion; the permeability of ion channels; gene expression; cell proliferation and survival. Indeed, it can be argued that the discovery of cyclic AMP initiated the study of intracellular signaling pathways, a major focus of contemporary biomedical inquiry. This review presents relevant details of Sutherland's career; summarizes key contributions of his mentors, Carl and Gerti Cori, to the knowledge of glycogen metabolism (contributions that were the foundation for his own research); describes the experiments that led to his identification, isolation, and characterization of cyclic AMP; assesses the significance of his work; and considers some aspects of the impact of cyclic nucleotide research on clinical medicine.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
α-D-Glucose 1-phosphate disodium salt hydrate, ≥97% (Enzymatic Purity, anhydrous)
Sigma-Aldrich
α-D-Glucose 1-phosphate dipotassium salt hydrate, ≥99% (HPLC), BioXtra
Sigma-Aldrich
α-D-Glucose 1-phosphate dipotassium salt hydrate, ≥97% (HPLC)